Literature DB >> 15875061

The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience.

J C Cappelleri1, R C Rosen.   

Abstract

The Sexual Health Inventory for Men (SHIM) is a widely used scale for screening and diagnosis of erectile dysfunction (ED) and severity of ED in clinical practice and research. In reviewing the SHIM-related literature, we sought to provide a compendium of studies in which the SHIM was used, to provide a systematic framework for organizing and evaluating the studies, and to provide a status report on the SHIM and its impact on the management of male sexual dysfunction. Using a Medline search, we found that the SHIM was an integral measure in at least 21 studies on the prevalence of ED, 23 studies on the efficacy of ED interventions, and eight other (mainly correlational) studies. The quantity of research and quality of scholarship on the SHIM provide testimony to its positive impact on understanding and improving male sexual function. These scientific contributions are likely to remain influential in coming years.

Entities:  

Mesh:

Year:  2005        PMID: 15875061     DOI: 10.1038/sj.ijir.3901327

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  64 in total

1.  Effect of cardiac resynchronization therapy on libido and erectile dysfunction.

Authors:  Ahmet Vural; Aysen Agacdiken; Umut Celikyurt; Melih Culha; Goksel Kahraman; Guliz Kozdag; Dilek Ural
Journal:  Clin Cardiol       Date:  2011-06-02       Impact factor: 2.882

2.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

3.  Microscopic polyangiitis with sexual and reproductive system involvement: first description of a case.

Authors:  Massimiliano Rocchietti March; Flavia Del Porto; Maria Proietta; Bruno Laganà; Raffaele D'Amelio; Giuseppe Aliberti
Journal:  Intern Emerg Med       Date:  2008-02-14       Impact factor: 3.397

4.  Treatment of pituitary prolactinoma reverses unresponsiveness to PDE5 inhibitor therapy in men with ED and SHPRL.

Authors:  Tao Jiang; Lei Zheng; Xiao-Ming Su; Jin-Qiang Peng; Dong-Cheng Sun; Quan-Lin Li; Zhi-Wei Zhang; Fa-Peng Wang; Hui Jiang
Journal:  Asian J Androl       Date:  2013-07-29       Impact factor: 3.285

5.  A matched-pair comparison between bilateral intrafascial and interfascial nerve-sparing techniques in extraperitoneal laparoscopic radical prostatectomy.

Authors:  Tao Zheng; Xu Zhang; Xin Ma; Hong-Zhao Li; Jiang-Pin Gao; Wei Cai; Jun Dong; Guang-Fu Chen; Bao-Jun Wang; Tao-Ping Shi; Er-Lin Song; Wei-Hao Chen; Qing-Bo Huang
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

Review 6.  Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.

Authors:  Vinay Prabhu; Ted Lee; Tyler R McClintock; Herbert Lepor
Journal:  Rev Urol       Date:  2013

7.  Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly's Canadian 40over40 Erectile Dysfunction Campaign.

Authors:  Jean-Christophe Bélisle Pipon; Bryn Williams-Jones
Journal:  Healthc Policy       Date:  2015-05

8.  Time-related increase in urinary testosterone levels and stable semen analysis parameters after bariatric surgery in men.

Authors:  Richard S Legro; Allen R Kunselman; Juliana W Meadows; James S Kesner; Edward F Krieg; Ann M Rogers; Robert N Cooney
Journal:  Reprod Biomed Online       Date:  2014-11-05       Impact factor: 3.828

9.  Seamless integration of clinical care and research in an innovative fertility preservation program: the Colorado Oncofertility Program model.

Authors:  Kiara Blough; Chanel Mansfield; Laxmi A Kondapalli
Journal:  J Cancer Surviv       Date:  2014-05-08       Impact factor: 4.442

Review 10.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.